未登录

M

Mark Wheatley

coventry university

H指数:34

被引数:3,909

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Doxorubicin increases G-protein coupled receptor-mediated vasoconstriction in coronary arteries via the mitogen-activated protein kinase kinase 1/2 pathway

多柔比星通过丝裂原活化蛋白激酶激酶1/2通路增加冠状动脉中G蛋白偶联受体介导的血管收缩。

European Journal of Pharmacology

IF4.7

2025-09-150

PRE

Tunable Terpolymer Series for the Systematic Investigation of Membrane Proteins

BIOMACROMOLECULES

IF5.4

2024-12-260

PRE

GPCRs in the round: SMA-like copolymers and SMALPs as a platform for investigating GPCRs

ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS

IF3

2024-04-014

OAAI

Doxorubicin alters G-protein coupled receptor-mediated vasocontraction in rat coronary arteries

NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY

IF3.1

2024-02-080

PRE

Differences in SMA-like polymer architecture dictate the conformational changes exhibited by the membrane protein rhodopsin encapsulated in lipid nano-particles

IF5.1

2021-01-0115

OAAI

Single molecule binding of a ligand to a G-protein-coupled receptor in real time using fluorescence correlation spectroscopy, rendered possible by nano-encapsulation in styrene maleic acid lipid particles

IF5.1

2020-01-0139

OAAI

An acid-compatible co-polymer for the solubilization of membranes and proteins into lipid bilayer-containing nanoparticles

IF5.1

2018-01-0189

OAAI

GPCR-styrene maleic acid lipid particles (GPCR-SMALPs): their nature and potential

BIOCHEMICAL SOCIETY TRANSACTIONS

IF4.3

2016-04-1142

OAAI

G-protein coupled receptor solubilization and purification for biophysical analysis and functional studies, in the total absence of detergent

BIOSCIENCE REPORTS

IF4.7

2015-04-1692

OAAI

Structural analysis of a nanoparticle containing a lipid bilayer used for detergent-free extraction of membrane proteins

用于无去污剂提取膜蛋白的含有脂质双层的纳米颗粒的结构分析

IF9

2014-10-23165

OAAI

The activation of the CGRP receptor

BIOCHEMICAL SOCIETY TRANSACTIONS

IF4.3

2013-01-2918

PREAI

G-Protein-Coupled Receptors: from Structural Insights to Functional Mechanisms

BIOCHEMICAL SOCIETY TRANSACTIONS

IF4.3

2013-01-2913

PREAI

The role of the extracellular loops of the CGRP receptor, a family B GPCR

BIOCHEMICAL SOCIETY TRANSACTIONS

IF4.3

2012-03-2115

PREAI

Lifting the lid on GPCRs: the role of extracellular loops

BRITISH JOURNAL OF PHARMACOLOGY

IF7.7

2012-02-22275

OAAI

Surfactant-free purification of membrane proteins with intact native membrane environment

BIOCHEMICAL SOCIETY TRANSACTIONS

IF4.3

2011-05-20104

PREAI

Agonist-specific requirement for a glutamate in transmembrane helix 1 of the oxytocin receptor

MOLECULAR AND CELLULAR ENDOCRINOLOGY

IF3.6

2011-02-106

PREAI

Novel strategies for the design of receptor-selective vasopressin analogues:: Aib-substitution and retro-inverso transformation

BRITISH JOURNAL OF PHARMACOLOGY

IF7.7

2009-01-2913

OAAI

Targeting V1A-vasopressin receptors with [Arg6, D-Trp7,9, NmePhe8]-substance P (6-11) identifies a strategy to develop novel anti-cancer therapies

BRITISH JOURNAL OF PHARMACOLOGY

IF7.7

2008-12-2414

OAAI

Ligand binding and activation of the CGRP receptor

BIOCHEMICAL SOCIETY TRANSACTIONS

IF4.3

2007-07-2051

PREAI

Extracellular loops and ligand binding to a subfamily of Family A G-protein-coupled receptors

BIOCHEMICAL SOCIETY TRANSACTIONS

IF4.3

2007-07-2023

PREAI